secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xtant Medical Holdings, Inc. (XTNT)
CIK:        0001453593
Form:       8-K
Filed at:   2023-07-11T23:59:59+00:00
Accession:  0001493152-23-024228
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xtant Medical extends deadline to terminate Surgalign asset purchase agreement to July 20, 2023
--------------------------------------------------------------------------------

- First Amendment extends Xtant's termination right deadline from July 10 to July 20, 2023 for reviewing disclosure schedules.
- Amends mutual release provisions in the original Asset Purchase Agreement to clarify scope.
- Original deal: Xtant pays $5M cash for hardware/biologics assets of Surgalign in Chapter 11.
- Xtant is stalking horse bidder; auction may result in higher or better offers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453593/000149315223024228/0001493152-23-024228-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453593/000149315223024228/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-024228

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer